Avidity Biosciences Statistics
Total Valuation
RNA has a market cap or net worth of $1.82 billion. The enterprise value is $1.28 billion.
| Market Cap | 1.82B |
| Enterprise Value | 1.28B |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, after market close.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
RNA has 79.72 million shares outstanding.
| Shares Outstanding | 79.72M |
| Owned by Insiders (%) | 6.41% |
| Owned by Institutions (%) | 85.62% |
| Float | 67.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 195.67 |
| Forward PS | 137.10 |
| PB Ratio | 3.74 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 134.40 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.58, with a Debt / Equity ratio of 0.02.
| Current Ratio | 7.58 |
| Quick Ratio | n/a |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -39.70% and return on invested capital (ROIC) is -46.14%.
| Return on Equity (ROE) | -39.70% |
| Return on Assets (ROA) | -35.00% |
| Return on Capital (ROIC) | -46.14% |
| Revenue Per Employee | $37,787 |
| Profits Per Employee | -$838,814 |
| Employee Count | 253 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +42.93% in the last 52 weeks. The beta is 0.77, so RNA's price volatility has been lower than the market average.
| Beta (1Y) | 0.77 |
| 52-Week Price Change | +42.93% |
| 50-Day Moving Average | 20.59 |
| 200-Day Moving Average | 11.28 |
| Relative Strength Index (RSI) | 48.01 |
| Average Volume (30 Days) | 1,193,664 |
Short Selling Information
| Short Interest | 9.98M |
| Short Previous Month | 8.62M |
| Short % of Shares Out | 12.66% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 6.00 |
Income Statement
In the last 12 months, RNA had revenue of $9.56 million and -$212.22 million in losses. Loss per share was -$2.91.
| Revenue | 9.56M |
| Gross Profit | 9.56M |
| Operating Income | -235.60M |
| Pretax Income | -212.22M |
| Net Income | -212.22M |
| EBITDA | -207.14M |
| EBIT | -212.22M |
| Loss Per Share | -$2.91 |
Balance Sheet
The company has $595.65 million in cash and $9.85 million in debt, giving a net cash position of $585.79 million or $7.35 per share.
| Cash & Cash Equivalents | 595.65M |
| Total Debt | 9.85M |
| Net Cash | 585.79M |
| Net Cash Per Share | $7.35 |
| Equity / Book Value | 500.76M |
| Book Value Per Share | 6.28 |
| Working Capital | 530.63M |
Cash Flow
In the last 12 months, operating cash flow was -$119.06 million and capital expenditures -$4.23 million, giving a free cash flow of -$123.29 million.
| Operating Cash Flow | -119.06M |
| Capital Expenditures | -4.23M |
| Free Cash Flow | -123.29M |
| FCF Per Share | -$1.69 |
Margins
Gross margin is 100.00%, with operating and profit margins of -2,464.41% and -2,219.87%.
| Gross Margin | 100.00% |
| Operating Margin | -2,464.41% |
| Pretax Margin | -2,219.87% |
| Profit Margin | -2,219.87% |
| EBITDA Margin | -2,166.75% |
| EBIT Margin | -2,219.87% |
| FCF Margin | -1,289.67% |
Dividends & Yields
RNA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -39.97% |
| Shareholder Yield | -39.97% |
| Earnings Yield | -11.34% |
| FCF Yield | -6.59% |
Analyst Forecast
The average price target for RNA is $38.00, which is 66.52% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $38.00 |
| Price Target Difference | 66.52% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 166.74% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RNA has an Altman Z-Score of 7.43 and a Piotroski F-Score of 2.
| Altman Z-Score | 7.43 |
| Piotroski F-Score | 2 |